Organon & Co. (OGN) has a market capitalization of $2.26B and trades at $8.70. The 52-week range is 5.69-13.28.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 12.1, Earnings Per Share (EPS) of $0.72, annual revenue of $6.22B.
The stock has a beta of 0.64, a last dividend of $0.0800, operates in the Healthcare sector.
